新秀麗(01910.HK)中期由盈轉虧9.74億美元
格隆匯8月19日丨新秀麗(01910.HK)公告,截至2020年6月30日止6個月,公司銷售淨額8.02億美元,同比減少54.3%;公司擁有人應占虧損9.74億美元,上年同期溢利4910萬美元;經調整EBITDA負1.23億美元,上年同期2.135億美元;每股虧損0.68美元。
銷售淨額減少是由於2019冠狀病毒疫症大流行的不利影響所致。
截至2020年6月30日止6個月的毛利率為49.4%,而去年同期則為56.0%。毛利率下降主要是由於2019冠狀病毒疫症大流行造成的不利影響導致銷售淨額按年減少,令毛利減少59.7%(按不變匯率基準計算則減少58.8%)所致。有關不利影響包括銷售淨額及產量降低但生產成本固定及存貨儲備增加的影響所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.